glp 1 drug made by eli lilly Gets Speedy FDA Nod for Oral GLP-1 Drug, a Competitor to New Novo Nordisk Pill Eli Lilly's Obesity Pill Appears
Description
March 6, 2023

Diabetes Care 33 , 11731175 (2010)

While these results are encouraging, larger trials in broader patient populations are needed to confirm its effects
Liraglutides safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: A randomized, double-blind, placebo-controlled trial
Consequently, several therapeutic approaches have aimed to antagonize GCG activity in the management of T2DM